482 related articles for article (PubMed ID: 34729791)
1. Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases.
Wang L; Li J; Di LJ
Med Res Rev; 2022 Mar; 42(2):946-982. PubMed ID: 34729791
[TBL] [Abstract][Full Text] [Related]
2. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.
Kotliarova S; Pastorino S; Kovell LC; Kotliarov Y; Song H; Zhang W; Bailey R; Maric D; Zenklusen JC; Lee J; Fine HA
Cancer Res; 2008 Aug; 68(16):6643-51. PubMed ID: 18701488
[TBL] [Abstract][Full Text] [Related]
4. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases.
Zhu Y; Wang H; Guo Y; Cao J; Li H
Mini Rev Med Chem; 2023; 23(19):1893-1904. PubMed ID: 37055897
[TBL] [Abstract][Full Text] [Related]
5. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
[TBL] [Abstract][Full Text] [Related]
6. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
Dokken BB; Sloniger JA; Henriksen EJ
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
[TBL] [Abstract][Full Text] [Related]
7. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis.
McManus EJ; Sakamoto K; Armit LJ; Ronaldson L; Shpiro N; Marquez R; Alessi DR
EMBO J; 2005 Apr; 24(8):1571-83. PubMed ID: 15791206
[TBL] [Abstract][Full Text] [Related]
8. The role of GSK3 in glucose homeostasis and the development of insulin resistance.
Lee J; Kim MS
Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S49-57. PubMed ID: 17478001
[TBL] [Abstract][Full Text] [Related]
9. Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle.
Bouskila M; Hirshman MF; Jensen J; Goodyear LJ; Sakamoto K
Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E28-35. PubMed ID: 18003720
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3: more than a namesake.
Rayasam GV; Tulasi VK; Sodhi R; Davis JA; Ray A
Br J Pharmacol; 2009 Mar; 156(6):885-98. PubMed ID: 19366350
[TBL] [Abstract][Full Text] [Related]
11. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
12. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.
Sugden PH; Fuller SJ; Weiss SC; Clerk A
Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S137-53. PubMed ID: 18204489
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
Beurel E; Grieco SF; Jope RS
Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
[TBL] [Abstract][Full Text] [Related]
14. Macrophage Function and the Role of GSK3.
Patel S; Werstuck GH
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672232
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functions.
Wang L; Zuo B; Xu D; Ren Z; Zhang H; Li X; Lei M; Xiong Y
PLoS One; 2012; 7(7):e40250. PubMed ID: 22792253
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells.
MacAulay K; Blair AS; Hajduch E; Terashima T; Baba O; Sutherland C; Hundal HS
J Biol Chem; 2005 Mar; 280(10):9509-18. PubMed ID: 15632169
[TBL] [Abstract][Full Text] [Related]
17. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.
Wagman AS; Johnson KW; Bussiere DE
Curr Pharm Des; 2004; 10(10):1105-37. PubMed ID: 15078145
[TBL] [Abstract][Full Text] [Related]
18. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
Wadhwa P; Jain P; Jadhav HR
Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
[TBL] [Abstract][Full Text] [Related]
19. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
Pardo M; Abrial E; Jope RS; Beurel E
Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
[TBL] [Abstract][Full Text] [Related]
20. Effects of prior exercise on components of insulin signalling in equine skeletal muscle.
McCutcheon LJ; Geor RJ; Pratt SE; Martineau E; Ho K
Equine Vet J Suppl; 2006 Aug; (36):330-4. PubMed ID: 17402442
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]